Plain-English translation of NCT04292067 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers want to understand whether people with spondyloarthritis or rheumatoid arthritis have different gut bacteria than healthy people. By studying stool and blood samples from patients and healthy volunteers, they hope to identify specific bacterial patterns that may be connected to these joint diseases.
Scientists have noticed that gut bacteria may play a role in arthritis, but they don't yet understand exactly how or which bacteria are involved. This study aims to find those connections so that future treatments might target the gut microbiome to help people with arthritis.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will provide a stool sample and a blood sample, which researchers will analyze to study your gut bacteria composition. You may also answer questions about your age, disease duration, current medications, and other clinical information. The study takes place at Ambroise Paré Hospital in Paris, and researchers will compare your samples to those of other arthritis patients and healthy volunteers.
AI-generated summary from trial data · Jun 11, 2026 · Not medical advice
France
Sponsor
Assistance Publique - Hôpitaux de Paris
Enrollment target
~400 participants
Started
November 2020
Primary completion
November 2026
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Last updated on clinicaltrials.gov in June 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Maxime BREBAN, MD, PhD
Service de Rhumatologie, Hôpital Ambroise Paré, APHP
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.